2211 — Universal Health International Holding Cashflow Statement
0.000.00%
- HK$202.30m
- HK$215.04m
- CNY711.51m
Annual cashflow statement for Universal Health International Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -676 | -188 | -106 | 0.58 | -25.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 233 | 18.3 | 26.6 | -27.1 | 5.68 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 227 | 101 | 45.1 | -89.3 | -53.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -108 | -42.4 | -18.2 | -102 | -59.8 |
| Capital Expenditures | -1.9 | -0.101 | -0.061 | -0.017 | -0.068 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 21.6 | 11.2 | -7.96 | 54.9 | 42.5 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 19.7 | 11.1 | -8.02 | 54.9 | 42.4 |
| Financing Cash Flow Items | — | — | — | 30.6 | 25 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10.2 | 56 | 11.3 | 40.2 | -5.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -98.2 | 24.7 | -14.8 | -6.63 | -23 |